全文获取类型
收费全文 | 2198篇 |
免费 | 187篇 |
国内免费 | 65篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 83篇 |
妇产科学 | 68篇 |
基础医学 | 337篇 |
口腔科学 | 31篇 |
临床医学 | 225篇 |
内科学 | 312篇 |
皮肤病学 | 168篇 |
神经病学 | 174篇 |
特种医学 | 190篇 |
外科学 | 276篇 |
综合类 | 79篇 |
预防医学 | 203篇 |
眼科学 | 14篇 |
药学 | 198篇 |
中国医学 | 3篇 |
肿瘤学 | 77篇 |
出版年
2021年 | 34篇 |
2019年 | 22篇 |
2018年 | 30篇 |
2017年 | 25篇 |
2016年 | 27篇 |
2015年 | 33篇 |
2014年 | 44篇 |
2013年 | 63篇 |
2012年 | 65篇 |
2011年 | 79篇 |
2010年 | 58篇 |
2009年 | 40篇 |
2008年 | 53篇 |
2007年 | 101篇 |
2006年 | 65篇 |
2005年 | 66篇 |
2004年 | 61篇 |
2003年 | 48篇 |
2002年 | 60篇 |
2001年 | 66篇 |
2000年 | 70篇 |
1999年 | 66篇 |
1998年 | 53篇 |
1997年 | 66篇 |
1996年 | 46篇 |
1995年 | 50篇 |
1994年 | 35篇 |
1993年 | 53篇 |
1992年 | 52篇 |
1991年 | 57篇 |
1990年 | 74篇 |
1989年 | 77篇 |
1988年 | 43篇 |
1987年 | 58篇 |
1986年 | 50篇 |
1985年 | 43篇 |
1984年 | 50篇 |
1983年 | 36篇 |
1982年 | 21篇 |
1981年 | 22篇 |
1980年 | 31篇 |
1979年 | 24篇 |
1978年 | 18篇 |
1977年 | 21篇 |
1976年 | 20篇 |
1975年 | 18篇 |
1974年 | 20篇 |
1971年 | 20篇 |
1969年 | 22篇 |
1968年 | 18篇 |
排序方式: 共有2450条查询结果,搜索用时 31 毫秒
1.
The initial management of bladder outflow obstruction typically related to benign prostatic hyperplasia (BPH) falls to a large extent within the remit of general practice. Referral onwards to secondary care typically arises following the failure to respond to conservative measures or when complications have supervened; the most significant of which is urinary retention. In the hospital setting, anaesthesia, constipation and immobility are the common precipitants. What follows is a practical guide to the management of these situations and provides an overview of the conservative, medical, minimally invasive and surgical treatments available. 相似文献
2.
G E Davies A V Thompson Z Niewola G E Burrows E L Teasdale D J Bird D A Phillips 《Occupational and environmental medicine》1983,40(4):442-449
Twenty four volunteers who had been allergic to laboratory animals for some years were examined by means of a questionnaire paying particular attention to symptoms associated with rats and by serological and skin tests with extracts of rat urine (retrospective study). Nasal and eye symptoms were reported by 21 and 16 individuals respectively: 13 had asthma. Positive skin tests and high levels of specific IgE antibody to rat urine extract were found in 17 of the more severely affected individuals and this group included 12 of those with asthma. Latent periods of work with animals before symptoms appeared varied from 0.5 to 12 years. Also 148 individuals were studied during their first year of work with animals (prospective study). Symptoms developing during the year were reported by 15%, asthma by 2%. IgE antibody levels to rat urine were raised in 40% of affected and 6% of the unaffected individuals but there was no significant correlation between symptoms and either antibody levels or positive skin tests. Allergic symptoms developing during the first year of postemployment were, on the whole, much milder than those seen in the retrospective study. A tentative conclusion is that most individuals who become allergic to laboratory animals develop the condition in a mild form during their first year of employment but it appears probable that atopic individuals, although having an equal chance of developing allergy as compared with non-atopic individuals, may eventually progress to a more severe form of the disease. 相似文献
3.
4.
5.
Inhibition of PAF-induced eosinophil accumulation in pulmonary airways of guinea pigs by anti-asthma drugs 总被引:3,自引:0,他引:3
S Sanjar S Aoki K Boubekeur L Burrows I Colditz I Chapman J Morley 《Japanese journal of pharmacology》1989,51(2):167-172
Intraperitoneal (i.p.) injection of platelet activating factor (PAF) in guinea pigs caused a dose-related increase in the number of eosinophils recovered from bronchoalveolar lavage fluid (BALF). The prevalence of eosinophils in BALF had significantly increased within 1 hr of i.p. injection of PAF (10 micrograms/animal) and was maximal after 24 hr. Subcutaneous osmotic mini-pumps were used to administer drugs for 5 days prior to i.p. injection of PAF (10 micrograms/animal) and for the subsequent 24 hr. The percentage increase of eosinophils in BALF, due to PAF, was inhibited in animals treated with dexamethasone, aminophylline, cromoglycate, tranilast or ketotifen, but not in animals treated with oxatomide, azelastine, amlexanox, ibudilast or AA-861. These results suggest that inhibition of pulmonary eosinophilia may be a necessary property of prophylactic anti-asthma drugs and provide indirect evidence favoring a role for PAF in eosinophilia of asthma. 相似文献
6.
Treatment of deoxynivalenol [3] in MeOH with hypochlorite bleach containing added NaOH gave rise to a single major product, the 9 alpha, 10 alpha, 12 beta, 13 beta-diepoxy-8,15-hemiketal 4. Thus, the reaction followed a very different course from that observed for verrucarol [2], where rearrangement involving opening of the starting 12,13-epoxide and a haloform-like oxidation took place. 相似文献
7.
8.
9.
10.
Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy 总被引:5,自引:3,他引:2 下载免费PDF全文
J M Moutquin P R Garner R F Burrows E Rey M E Helewa I R Lange S W Rabkin 《Canadian Medical Association journal》1997,157(7):907-919
OBJECTIVE: To provide Canadian physicians with comprehensive, evidence-based guidelines for the nonpharmacologic management and prevention of gestational hypertension and pre-existing hypertension during pregnancy. OPTIONS: Lifestyle modifications, dietary or nutrient interventions, plasma volume expansion and use of prostaglandin precursors or inhibitors. OUTCOMES: In gestational hypertension, prevention of complications and death related to either its occurrence (primary or secondary prevention) or its severity (tertiary prevention). In pre-existing hypertension, prevention of superimposed gestational hypertension and intrauterine growth retardation. EVIDENCE: Articles retrieved from the pregnancy and childbirth module of the Cochrane Database of Systematic Reviews; pertinent articles published from 1966 to 1996, retrieved through a MEDLINE search; and review of original randomized trials from 1942 to 1996. If evidence was unavailable, consensus was reached by the members of the consensus panel set up by the Canadian Hypertension Society. VALUES: High priority was given to prevention of adverse maternal and neonatal outcomes in pregnancies with established hypertension and in those at high risk of gestational hypertension through the provision of effective nonpharmacologic management. BENEFITS, HARMS AND COSTS: Reduction in rate of long-term hospital admissions among women with gestational hypertension, with establishment of safe home-care blood pressure monitoring and appropriate rest. Targeting prophylactic interventions in selected high-risk groups may avoid ineffective use in the general population. Cost was not considered. RECOMMENDATION: Nonpharmacologic management should be considered for pregnant women with a systolic blood pressure of 140-150 mm Hg or a diastolic pressure of 90-99 mm Hg, or both, measured in a clinical setting. A short-term hospital stay may be required for diagnosis and for ruling out severe gestational hypertension (preeclampsia). In the latter case, the only effective treatment is delivery. Palliative management, dependent on blood pressure, gestational age and presence of associated maternal and fetal risk factors, includes close supervision, limitation of activities and some bed rest. A normal diet without salt restriction is advised. Promising preventive interventions that may reduce the incidence of gestational hypertension, especially with proteinuria, include calcium supplementation (2 g/d), fish oil supplementation and low-dose acetylsalicylic acid therapy, particularly in women at high risk for early-onset gestational hypertension. Pre-existing hypertension should be managed the same way as before pregnancy. However, additional concerns are the effects on fetal well-being and the worsening of hypertension during the second half of pregnancy. There is, as yet, no treatment that will prevent exacerbation of the condition. VALIDATION: The guidelines share the principles in consensus reports from the US and Australia on the nonpharmacologic management of hypertension in pregnancy. 相似文献